Chongqing Pharscin Pharmaceutical News

Watson Pharmaceuticals: Announcement on pre-disclosure of the company\'s controlling shareholder\'s shareholding reduction

Oct 22 00:00

Watson Pharmaceuticals: 2024 Semi-Annual Equity Distribution Implementation Notice

Sep 4 00:00

Chongqing Pharscin Pharmaceutical: Announcement Regarding Profit Distribution Plan for H1 2024.

Aug 22 00:00

Chongqing Pharscin Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice

May 28 00:00

Watson Pharmaceuticals: Announcement on 2023 Profit Distribution Plan

Apr 10 00:00

Watson Pharmaceutical: Announcement on the release of the pledge of the company\'s shareholders\' shares

Dec 14, 2023 00:00

Watson Pharmaceutical: Announcement on the lifting of the freeze on the company\'s shareholders\' shares

Nov 18, 2023 00:00

Watson Pharmaceutical: Watson Pharmaceutical: 2022 Annual Equity Distribution Implementation Notice

Jun 5, 2023 00:00

Watson Pharmaceuticals: Announcement on 2022 Profit Distribution Plan

Apr 28, 2023 00:00

Watson Pharmaceutical: Announcement on the cancellation of the pledge of part of the company's shareholders' shares

Feb 4, 2023 00:00

Watson Pharmaceuticals: Important Reminder Announcement on the Imminent Suspension of the Stock Exchange of Watson Bonds and the Last Half of the Trading Day Before Redemption

Dec 15, 2022 11:42

Watson Pharmaceutical: Important Reminder Announcement on the “Watson Convertible Bonds” Will Stop Converting Shares and the Last Trading Day Before Redemption

Dec 15, 2022 00:00

Watson Pharmaceuticals: Important Reminder Announcement on the Implementation of the Watson Debt Transfer Redemption and the Imminent Suspension of Stock Conversion

Dec 14, 2022 00:00

Watson Pharmaceutical: Announcement on early termination of holdings reduction plans and share reduction results by shareholders, directors and senior managers holding 5% or more of the company's shares

Nov 1, 2022 00:00

Watson Pharmaceutical: Announcement on the progress of shareholders, directors and senior management holding 5% or more of the company\'s shares that have passed half of the planned share reduction period

Oct 11, 2022 00:00

Watson Pharmaceuticals: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2022

Oct 11, 2022 00:00

Watson Pharmaceutical: Notice on the freezing of the company\'s shareholders\' shares

Aug 29, 2022 00:00

Watson Pharmaceutical: Announcement on not revising the “Watson Convertible Bonds” stock conversion price downward

Aug 24, 2022 00:00

Watson Pharmaceuticals: An indicative announcement on the conditions expected to trigger a decline in the price of Watson debt-for-equity swaps

Aug 17, 2022 00:00

Watson Pharmaceutical: Announcement on the adjustment of the price of Watson debt-to-equity conversion

Jul 7, 2022 00:00